COVID-19 in Oncologic Patients: a Clinical-Epidemiological Profile Review

• Autor(a) principal: Alcântara, Rafaela Campos
• Data de Publicação: 2020
• Outros Autores: Silva Junior, Luiz Carlos Francelino, Arnozo, Gabriel Monteiro, Oliveira, Tatiana Farias de, Santana, Fernanda Mayara Santos, Silva Filho, Etvaldo Rodrigues da, Santos, Aisla Graciele Galdino dos, Cunha, Euclides José Oliveira da, Aquino, Saulo Henrique Salgueiro de, Mesquita, Rodrigo da Rosa, Souza, Carlos Dornels Freire de
• Tipo de documento: Artigo
• Idioma: por; eng
• Título da fonte: Revista Brasileira de Cancerologia (Online)
• Texto Completo: https://rbc.inca.gov.br/index.php/revista/article/view/1046
• topic: Infecções por Coronavirus; Neoplasias/epidemiologia; Revisão; Coronavirus Infections; Neoplasms/epidemiology; Review; Infecciones por Coronavirus; Neoplasias/epidemiología; Revisión

Introduction: Since the beginning of COVID-19 pandemic, studies indicate that oncologic patients represent one of the main risk groups. Objective: To synthesize the literature addressing clinical and epidemiological profile of oncologic patients with COVID-19. Method: A systematic review of the literature was carried out in the PubMed database, utilizing the descriptors COVID-19, SARS-CoV-2, 2019-nCoV, n-CoV and coronavirus combined with cancer, tumor and malignancy. Results: Of the 821 articles found, nine texts were included in the qualitative analysis, totaling 39 individuals, predominantly male (74.4% men): China (6 texts, 35 patients), Nigeria (1 text, 1 patient), France (1 text, 2 patients), Denmark (1 text, 1 patient). Lung (51.3%; n=20) and breast (10.3%; n=4) cancers were the most prevalent. In 87.2% (n=34), information about life habits were not reported. Respiratory symptoms (46.8%; n=18) and fever (43.6%; n=17) stood out. Six patients died (15.4%), four were discharged due to cure (10.2%), two remained hospitalized until the study was published (5.2%) and for the other patients (69.3%, n=27), the manuscript did not inform the outcome. Conclusion: Adequate care for this special group of patients when infected with the new coronavirus is essential in pursuing better outcomes. Further studies are still needed to better understand how COVID-19 behaves in cancer patients.